Drug Type Autologous CAR-T |
Synonyms- |
Target |
Action inhibitors |
Mechanism CD44v6 inhibitors(CD44v6 inhibitors), Immunologic cytotoxicity, T lymphocyte replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acute Myeloid Leukemia | Phase 1 | Czechia | 27 Aug 2019 | |
| Acute Myeloid Leukemia | Phase 1 | Italy | 27 Aug 2019 | |
| Solid tumor | Phase 1 | Italy | - | |
| Hematologic Neoplasms | Preclinical | Italy | - |





